By further evaluating the clinical significance of the ratio of GLN catabolism to anabolism, it was found that ovarian cancer patients with high GLS protein expression were associated with lower overall survival compared with patients having high GLUL protein expression (43). This evidence concerns the gene GLS and ovarian cancer.